# Zilganersen Expanded Access Program for Individuals With Alexander Disease

> **NCT07487389** · — · AVAILABLE · sponsor: **Ionis Pharmaceuticals, Inc.**

## Conditions studied

- Alexander Disease

## Interventions

- **DRUG:** zilganersen

## Key facts

- **NCT ID:** NCT07487389
- **Lead sponsor:** Ionis Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07487389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07487389, "Zilganersen Expanded Access Program for Individuals With Alexander Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07487389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*